Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of Patients With Advanced ccRCC"

132 views
November 24, 2023
Comments 0
Login to view comments. Click here to Login